Almirall launches in Spain Balneum Intensive, an innovative formula against the peeling of the skin. The peeling is a common symptom in dermatological processes common as dry senile and atopy
No products for this manufacturer.
Almirall, international pharmaceutical company based on innovation and committed to health, whose headquarters is located in Barcelona (Spain), researches, develops, produces, and markets drugs R & D own and license with the purpose of improving the health and well-being of the people.
The therapeutic areas in which to focus its investigative resources are related to the treatment of asthma, COPD (chronic obstructive pulmonary disease), rheumatoid arthritis, multiple sclerosis, psoriasis and other dermatological conditions.
Currently, the drugs of Almirall are present in more than 70 countries, with direct presence in Europe and Latin America through 12 subsidiaries.